Please check back with us for the latest news, announcements, and updates at Park Allergy Center!
Cecilia Acuti Martellucci 1, Angelo Capodici 1, Graziella Soldato 2, Matteo Fiore 1, Enrico Zauli 3, Roberto Carota 2, Marco De Benedictis 2, Graziano Di Marco 2, Rossano Di Luzio 2, Maria Elena Flacco 4, Lamberto Manzoli 1
This study was done in the province of Pescara, Italy involving about 300,000 residents. It was conducted from June 2021 through December 2023 and published in July 2025. It is consistent with other reports over the past few years showing an increased risk for cancer from COVID shots. Here are some of its findings.
Overall cancer risk increased 23% (HR 1.23, 95% CI 1.11-1.37).
Breast cancer risk increased 54% (HR 1.54, 95% CI 1.10-2.26).
Bladder cancer risk increased 62% (HR 1.62, 95% CI 1.07-2.445).
Colon-rectum cancer risk increased 35% (HR 1.35, 95% CI 1.01-1.80).
The following cancers had increased risk with COVID shots but were not statistically significant: hematological, uterine, ovarian, thyroid, and prostate.
https://pubmed.ncbi.nlm.nih.gov/40881928
In a previous study published in 2024, Akkus et al demonstrated a link between the COVID shots and colon cancer.
Erman Akkus 1,✉, Bahar Karaoglan 1, Cihangir Akyol 2, Ali Ekrem Ünal 3, Mehmet Ayhan Kuzu 2, Berna Savaş 4, Güngör Utkan 1
In particular, the authors studied microsatellite instability-high (MSI-H) colon cancer, named because of the instability of the tumors cells due to genetic mutations. The study ran from June 2021 through June 2023 and was published in June 2024. Two COVID shots were used: Pfizer and CoronaVac. CoronaVac was an inactivated SARS-CoV-2 virus vaccine developed in China and available to several countries during the pandemic including Turkey.
The Pfizer shot was associated with a greater than 500% increased risk of developing MSI-H colon cancer (OR 6.39, 95% CI 1.55-26.26, p = 0.01).
No such increased risk was found with CoronaVac.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11227084
Finally, there is a recently published paper by Marik et al, COVID-19 mRNA-Induced “Turbo Cancers”. How do these shots cause cancer? The authors review the mechanisms involved. At the end of the paper, they offer suggestions for preventative measures.
Association Between COVID-19 Vaccination and Neuropsychiatric Conditions James A Thorp, MD 1, Claire Rogers, MSPAS, PA-C *2, Kirstin Cosgrove, CCRA 3 Steven Hatfill, MD M Med 4, Peter Breggin, MD 5, Drew Pinsky, MD 6, Peter A McCullough, MD, MPH 7
This study collected data from the CDC, FDA and VAERS database from 1990 through 2024. It was published in June 2025. Its findings are alarming to say the least. It used Proportional Reporting Ratios (PRRs) to compare numbers of Adverse Events reports after COVID shots with reports after influenza vaccinations and total vaccinations. A PRR of 1 means the number of reports were equal with both drugs. A PRR of 2 means there were twice as many reports in the study drug compared to the comparison drug. The CDC and FDA define a PRR of 2 or greater as the safety threshold to investigate a potential danger in the study drug.
ALL of the following Adverse Events had a PRR of far greater than 2. As you can see, many were greater than 100 (100 times as many reports compared to the comparison drug).




Multiple other studies have demonstrated the same catastrophic results.
https://pubmed.ncbi.nlm.nih.gov/39560882
https://pubmed.ncbi.nlm.nih.gov/38806183
https://pubmed.ncbi.nlm.nih.gov/38834668
Yes, COVID was a stressful time. But stress is not the primary reason our neurologists, psychiatrists, and psychologists have been so busy these past 5 years…
COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes Claire Rogers 1,*, James A Thorp 2,3, Kirstin Cosgrove 4 and Peter A McCullough 5
https://www.ijirms.in/index.php/ijirms/article/view/1982
This study used data from CDC, FDA, and VAERS databases from 1990 through 2023. It compared reports of Adverse Events after COVID shots compared to those after influenza vaccines and to all other vaccines. It did this by using Proportional Reporting Ratio (PRR). PRRs are a statistical measure to help detect whether a specific adverse event from one drug is reported more often compared to another. It is commonly used to identify potential safety signals. A PRR of 1 means the Adverse Event was reported at the same rate for both drugs. A PRR of 2 means the Adverse Event was reported twice as often in the subject drug compared to the comparison drug. Indeed, a PRR of 2 is the usual cut off to trigger a safety signal.
Cerebral Venous Thrombosis was reported 2000 times more often after COVID shots compared to influenza vaccinations (PRR 2070: 95% CI, 955-4490, p < 0.0001).
Cerebral Arterial Thrombosis was reported 1000 times more often after COVID shots compared to influenza vaccinations (PRR 1120: 95% CI, 152-8280, p < 0.0001).
Total Cerebral Thrombosis was reported 1000 times more often after COVID shots compared to influenza vaccinations (PRR 1120: 95% CI, 723-1730, p < 0.0001).
Atrial fibrillation was reported 100 times more often after COVID shots compared to all other vaccines (PRR 123: (95% CI, 88.3-172, p << 0.0001).
Further, the “Pfizer post-marketing analysis done from December 10, 2020 to February 28, 2021 [documented] 42,086 casualties including 1223 deaths in just the first 10 weeks of rollout.”*
*BNT162b2 5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021. Report prepared by Worldwide Safety Pfizer for the Federal Drug Administration and approved on April 30, 2021.https://phmpt.org/wp- content/uploads/2021/11/5.3.6-postmarketing-experience.pdf. (Accessed June 15, 2023).
By the way, this 10 week analysis is part of the Pfizer data that the FDA requested to stay sealed for 75 years. Well, they lost that lawsuit and in January 2022 a federal judge ruled that the FDA must expedite the release of these documents.
